Overview

Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study)

Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The FLOW-PROMOTE Study is an investigator-initiated, Danish multicenter study of patients with stable chest pain investigating whether lipid lowering is associated with recovery of impaired coronary flow as assessed by CT derived fractional flow reserve (FFRCT).
Phase:
Phase 3
Details
Lead Sponsor:
Bjarne Linde Noergaard
Treatments:
Rosuvastatin Calcium